Who is sponsoring NCT05941390?

NCT05941390 is sponsored by Assuta Ashdod Hospital.

What drugs are being tested in NCT05941390?

Interventions in NCT05941390: VR without positive psychology, VR with positive psychology.

What condition does NCT05941390 study?

NCT05941390 studies Virtual Reality, Anxiety, Pain.

Is NCT05941390 still recruiting?

NCT05941390 is currently status unknown. Last updated 3 August 2023.

Last reviewed 2023-08-03 · How we verify

NCT05941390: VR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Using Virtual Reality (VR) Technology in Gynecological and Obstetrics Procedures

Status unknown NA Last updated 3 August 2023

What this trial tests

NA trial testing VR without positive psychology in Virtual Reality in 270 participants. Status unknown.

Timeline

1 September 2023

Primary endpoint
1 September 2024

1 September 2024

Quick facts

Lead sponsor	Assuta Ashdod Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	270
Start date	1 September 2023
Primary completion	1 September 2024
Estimated completion	1 September 2024

Drugs / interventions tested

VR without positive psychology
VR with positive psychology

Conditions studied

Virtual Reality — all drugs for Virtual Reality →
Anxiety — all drugs for Anxiety →
Pain — all drugs for Pain →

Sponsor

Assuta Ashdod Hospital

Who can join

Adults 18 to 60, female only, with Virtual Reality or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized control trial will be conducted in Assuta Ashdod hospital, in the department of obstetrics and gynecology. Pregnant and non pregnant women, undergoing one of the procedures (external cephalic version,amniocentesis or hysteroscopy), will be approached. All willing patients meeting the criteria will sign an informed consent form will. After signing informed consent patients will be randomly allocated into three groups:1) control (no use of VR). 2) use of VR googles without positive psychology. 3) use of VR googles with positive psychology. Before and after the procedure each group will answer pain and anxiety questionnaires. In addition, following, following each procedure, salivary cortisol levels will be measured.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults · NA · recruiting
NCT07343843 — Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes Duri · NA · recruiting
NCT07410858 — Virtual Reality-Enhanced Parent Education in Neonatal Intensive Care · NA · recruiting
NCT07021638 — EMMVIES : Walking Training at Home in VIrtual Reality for Children With Chronic Illnesses Impacting Physical Health · NA · recruiting
NCT07236229 — The Effects of Immersive Virtual Reality in Patients With Grade 1-2 Adhesive Capsulitis · NA · recruiting

Other Assuta Ashdod Hospital trials

Trials by the same sponsor.

NCT07372547 — Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post-Void Residual Urine Volume (PVR) After Removal o · NA · recruiting
NCT05448456 — Use of Tranexamic Acid After Vaginal Delivery with Episiotomy a RCT Placebo Control Trail · Phase 4 · completed
NCT06009679 — MISOPROSTOL FOR THE TREATMENT OF SUSPECTED POSTPARTUM RETAINED PRODUCTS OF CONCEPTION · NA · unknown
NCT04210908 — Biofeedback for Second Stage of Labor · NA · completed
NCT04512820 — Treatment of Missed Miscarriage With TRUCLEAR Tissue Removal System, a Feasiblity Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05941390 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assuta Ashdod Hospital
Last refreshed: 3 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05941390.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing